Presentation + Paper
7 March 2019 ALDH3A2 as a potential molecular marker for nasopharyngeal carcinoma
Author Affiliations +
Proceedings Volume 10879, Biophotonics and Immune Responses XIV; 108790A (2019) https://doi.org/10.1117/12.2506121
Event: SPIE BiOS, 2019, San Francisco, California, United States
Abstract
Nasopharyngeal carcinoma (NPC) is a high incidence cancer in southern China and southeast Asia. For the growth and recurrence are in the concealed pharynx and larynx, NPC is difficult to be early diagnosed and effectively treated. Therefore, it is an ideal way to develop strategy for early targeted diagnosis and treatment. R4FLTV, a peptide which can specifically target human nasopharyngeal carcinoma tumor 5-8F, combined with nanoparticle could realize combination of diagnosis and treatment for subcutaneous 5-8F tumor model and lung metastasis in nude mice. By using pull down technology and protein spectrum analysis technique, we found that the ALDH3A2 could be a receptor and molecular marker in the 5-8F cells which targeted by R4FLTV peptide.
Conference Presentation
© (2019) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Shuhong Qi, Lisen Lu, and Zhihong Zhang "ALDH3A2 as a potential molecular marker for nasopharyngeal carcinoma", Proc. SPIE 10879, Biophotonics and Immune Responses XIV, 108790A (7 March 2019); https://doi.org/10.1117/12.2506121
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Proteins

Nanoparticles

Receptors

Confocal microscopy

Signal detection

Flow cytometry

Statistical analysis

Back to Top